Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Check out the new look and feel of Harvard Catalyst Profiles! Learn more on our About and Help pages.

Imran Rizvi, Ph.D.

Title
Institution
Department
Address
Phone
Profile Picture

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Rizvi I, Obaid G, Bano S, Hasan T, Kessel D. Photodynamic therapy: Promoting in vitro efficacy of photodynamic therapy by liposomal formulations of a photosensitizing agent. Lasers Surg Med. 2018 Mar 11. PMID: 29527710.
    View in: PubMed
  2. Broekgaarden M, Rizvi I, Bulin AL, Petrovic L, Goldschmidt R, Massodi I, Celli JP, Hasan T. Neoadjuvant photodynamic therapy augments immediate and prolonged oxaliplatin efficacy in metastatic pancreatic cancer organoids. Oncotarget. 2018 Feb 27; 9(16):13009-13022. PMID: 29560127.
    View in: PubMed
  3. Huang HC, Rizvi I, Liu J, Anbil S, Kalra A, Lee H, Baglo Y, Paz N, Hayden D, Pereira S, Pogue BW, Fitzgerald J, Hasan T. Photodynamic Priming Mitigates Chemotherapeutic Selection Pressures and Improves Drug Delivery. Cancer Res. 2018 Jan 15; 78(2):558-571. PMID: 29187403.
    View in: PubMed
  4. Huang HC, Liu J, Baglo Y, Rizvi I, Anbil S, Pigula M, Hasan T. Mechanism-informed Repurposing of Minocycline Overcomes Resistance to Topoisomerase Inhibition for Peritoneal Carcinomatosis. Mol Cancer Ther. 2018 Feb; 17(2):508-520. PMID: 29167313.
    View in: PubMed
  5. Huang HC, Mallidi S, Liu J, Chiang CT, Mai Z, Goldschmidt R, Ebrahim-Zadeh N, Rizvi I, Hasan T. Photodynamic Therapy Synergizes with Irinotecan to Overcome Compensatory Mechanisms and Improve Treatment Outcomes in Pancreatic Cancer. Cancer Res. 2016 Mar 01; 76(5):1066-77. PMID: 26719532; PMCID: PMC4775276 [Available on 03/01/17].
  6. Hempstead J, Jones DP, Ziouche A, Cramer GM, Rizvi I, Arnason S, Hasan T, Celli JP. Low-cost photodynamic therapy devices for global health settings: Characterization of battery-powered LED performance and smartphone imaging in 3D tumor models. Sci Rep. 2015 May 12; 5:10093. PMID: 25965295; PMCID: PMC4428052.
  7. Spring BQ, Rizvi I, Xu N, Hasan T. The role of photodynamic therapy in overcoming cancer drug resistance. Photochem Photobiol Sci. 2015 Aug; 14(8):1476-91. PMID: 25856800; PMCID: PMC4520758.
  8. Mallidi S, Mai Z, Rizvi I, Hempstead J, Arnason S, Celli J, Hasan T. In vivo evaluation of battery-operated light-emitting diode-based photodynamic therapy efficacy using tumor volume and biomarker expression as endpoints. J Biomed Opt. 2015 Apr; 20(4):048003. PMID: 25909707; PMCID: PMC4408448.
  9. Ghogare AA, Rizvi I, Hasan T, Greer A. "Pointsource" delivery of a photosensitizer drug and singlet oxygen: eradication of glioma cells in vitro. Photochem Photobiol. 2014 Sep-Oct; 90(5):1119-25. PMID: 24673689; PMCID: PMC4198175.
  10. Spring BQ, Abu-Yousif AO, Palanisami A, Rizvi I, Zheng X, Mai Z, Anbil S, Sears RB, Mensah LB, Goldschmidt R, Erdem SS, Oliva E, Hasan T. Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates. Proc Natl Acad Sci U S A. 2014 Mar 11; 111(10):E933-42. PMID: 24572574; PMCID: PMC3956156.
  11. Celli JP, Rizvi I, Blanden AR, Massodi I, Glidden MD, Pogue BW, Hasan T. An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models. Sci Rep. 2014 Jan 17; 4:3751. PMID: 24435043; PMCID: PMC3894557.
  12. Anbil S, Rizvi I, Celli JP, Alagic N, Pogue BW, Hasan T. Impact of treatment response metrics on photodynamic therapy planning and outcomes in a three-dimensional model of ovarian cancer. J Biomed Opt. 2013 Sep; 18(9):098004. PMID: 24802230; PMCID: PMC3783041.
  13. Rizvi I, Gurkan UA, Tasoglu S, Alagic N, Celli JP, Mensah LB, Mai Z, Demirci U, Hasan T. Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules. Proc Natl Acad Sci U S A. 2013 May 28; 110(22):E1974-83. PMID: 23645635; PMCID: PMC3670329.
  14. Rizvi I, Anbil S, Alagic N, Celli J, Celli JP, Zheng LZ, Palanisami A, Glidden MD, Pogue BW, Hasan T. PDT dose parameters impact tumoricidal durability and cell death pathways in a 3D ovarian cancer model. Photochem Photobiol. 2013 Jul-Aug; 89(4):942-52. PMID: 23442192; PMCID: PMC3701746.
  15. Glidden MD, Celli JP, Massodi I, Rizvi I, Pogue BW, Hasan T. Image-Based Quantification of Benzoporphyrin Derivative Uptake, Localization, and Photobleaching in 3D Tumor Models, for Optimization of PDT Parameters. Theranostics. 2012; 2(9):827-39. PMID: 23082096; PMCID: PMC3475211.
  16. Rizvi I, Dinh TA, Yu W, Chang Y, Sherwood ME, Hasan T. Photoimmunotherapy and irradiance modulation reduce chemotherapy cycles and toxicity in a murine model for ovarian carcinomatosis: perspective and results. Isr J Chem. 2012 Sep; 52(8-9):776-787. PMID: 23626376.
    View in: PubMed
  17. Evans CL, Abu-Yousif AO, Park YJ, Klein OJ, Celli JP, Rizvi I, Zheng X, Hasan T. Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT. PLoS One. 2011; 6(8):e23434. PMID: 21876751; PMCID: PMC3158086.
  18. Xu F, Celli J, Rizvi I, Moon S, Hasan T, Demirci U. A three-dimensional in vitro ovarian cancer coculture model using a high-throughput cell patterning platform. Biotechnol J. 2011 Feb; 6(2):204-212. PMID: 21298805; PMCID: PMC3780785.
  19. Rizvi I, Celli JP, Evans CL, Abu-Yousif AO, Muzikansky A, Pogue BW, Finkelstein D, Hasan T. Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer. Cancer Res. 2010 Nov 15; 70(22):9319-28. PMID: 21062986.
    View in: PubMed
  20. Rahmanzadeh R, Rai P, Celli JP, Rizvi I, Baron-Lühr B, Gerdes J, Hasan T. Ki-67 as a molecular target for therapy in an in vitro three-dimensional model for ovarian cancer. Cancer Res. 2010 Nov 15; 70(22):9234-42. PMID: 21045152.
    View in: PubMed
  21. Celli JP, Rizvi I, Evans CL, Abu-Yousif AO, Hasan T. Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent residual tumor distributions in a three-dimensional ovarian cancer model. J Biomed Opt. 2010 Sep-Oct; 15(5):051603. PMID: 21054077; PMCID: PMC2948043.
  22. Celli JP, Spring BQ, Rizvi I, Evans CL, Samkoe KS, Verma S, Pogue BW, Hasan T. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev. 2010 May 12; 110(5):2795-838. PMID: 20353192; PMCID: PMC2896821.
  23. Samkoe KS, Chen A, Rizvi I, O'Hara JA, Hoopes PJ, Pereira SP, Hasan T, Pogue BW. Imaging tumor variation in response to photodynamic therapy in pancreatic cancer xenograft models. Int J Radiat Oncol Biol Phys. 2010 Jan 01; 76(1):251-9. PMID: 20005458; PMCID: PMC2902770.
  24. Abu-Yousif AO, Rizvi I, Evans CL, Celli JP, Hasan T. PuraMatrix encapsulation of cancer cells. J Vis Exp. 2009 Dec 17; (34). PMID: 20019656; PMCID: PMC3152243.
  25. Zhong W, Celli JP, Rizvi I, Mai Z, Spring BQ, Yun SH, Hasan T. In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring. Br J Cancer. 2009 Dec 15; 101(12):2015-22. PMID: 19920823; PMCID: PMC2795438.
  26. Evans CL, Rizvi I, Hasan T, de Boer JF. In vitro ovarian tumor growth and treatment response dynamics visualized with time-lapse OCT imaging. Opt Express. 2009 May 25; 17(11):8892-906. PMID: 19466138; PMCID: PMC2836890.
  27. Laubach HJ, Chang SK, Lee S, Rizvi I, Zurakowski D, Davis SJ, Taylor CR, Hasan T. In-vivo singlet oxygen dosimetry of clinical 5-aminolevulinic acid photodynamic therapy. J Biomed Opt. 2008 Sep-Oct; 13(5):050504. PMID: 19021376; PMCID: PMC2994192.
  28. Chang SK, Rizvi I, Solban N, Hasan T. In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment. Clin Cancer Res. 2008 Jul 01; 14(13):4146-53. PMID: 18593993.
    View in: PubMed
  29. Kosharskyy B, Solban N, Chang SK, Rizvi I, Chang Y, Hasan T. A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer. Cancer Res. 2006 Nov 15; 66(22):10953-8. PMID: 17108133.
    View in: PubMed
  30. Yelin D, Rizvi I, White WM, Motz JT, Hasan T, Bouma BE, Tearney GJ. Three-dimensional miniature endoscopy. Nature. 2006 Oct 19; 443(7113):765. PMID: 17051200.
    View in: PubMed
  31. Solban N, Rizvi I, Hasan T. Targeted photodynamic therapy. Lasers Surg Med. 2006 Jun; 38(5):522-31. PMID: 16671102.
    View in: PubMed
  32. Shah S, Islam MN, Dakshanamurthy S, Rizvi I, Rao M, Herrell R, Zinser G, Valrance M, Aranda A, Moras D, Norman A, Welsh J, Byers SW. The molecular basis of vitamin D receptor and beta-catenin crossregulation. Mol Cell. 2006 Mar 17; 21(6):799-809. PMID: 16543149.
    View in: PubMed
  33. del Carmen MG, Rizvi I, Chang Y, Moor AC, Oliva E, Sherwood M, Pogue B, Hasan T. Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo. J Natl Cancer Inst. 2005 Oct 19; 97(20):1516-24. PMID: 16234565.
    View in: PubMed
  34. Hamblin MR, Miller JL, Rizvi I, Loew HG, Hasan T. Pegylation of charged polymer-photosensitiser conjugates: effects on photodynamic efficacy. Br J Cancer. 2003 Sep 01; 89(5):937-43. PMID: 12942129; PMCID: PMC2394480.
  35. Hamblin MR, Miller JL, Rizvi I, Ortel B. Degree of substitution of chlorin e6 on charged poly-L-lysine chains affects their cellular uptake, localization and phototoxicity towards macrophages and cancer cells. J Xray Sci Technol. 2002 Jan 01; 10(3):139-52. PMID: 22388044.
    View in: PubMed
  36. Hamblin MR, Miller JL, Rizvi I, Ortel B, Maytin EV, Hasan T. Pegylation of a chlorin(e6) polymer conjugate increases tumor targeting of photosensitizer. Cancer Res. 2001 Oct 01; 61(19):7155-62. PMID: 11585749.
    View in: PubMed
  37. Hamblin MR, Del Governatore M, Rizvi I, Hasan T. Biodistribution of charged 17.1A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancer. Br J Cancer. 2000 Dec; 83(11):1544-51. PMID: 11076666; PMCID: PMC2363424.
  38. Del Governatore M, Hamblin MR, Shea CR, Rizvi I, Molpus KG, Tanabe KK, Hasan T. Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1A chlorin(e6) immunoconjugate. Cancer Res. 2000 Aug 01; 60(15):4200-5. PMID: 10945630.
    View in: PubMed
  39. Molpus KL, Hamblin MR, Rizvi I, Hasan T. Intraperitoneal photoimmunotherapy of ovarian carcinoma xenografts in nude mice using charged photoimmunoconjugates. Gynecol Oncol. 2000 Mar; 76(3):397-404. PMID: 10684717.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Rizvi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (174)
Explore
_
Co-Authors (20)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_